# Dr. Liu Xiaoling

> Dr. Liu Xiaoling is a Series A investor at Emerging Technology Partners backing Medical. See 1 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: [Emerging Technology Partners](https://shizune.co/investors/profile/emerging-technology-partners)
- Location: Beijing, China
- Total investments: 1
- Last investment: Jan 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/xiaoling-liu-3a63543a

Dr. Liu Xiaoling is a Series A investor at Emerging Technology Partners in Beijing focused on Medical and Biopharma. Dr. Liu Xiaoling

## Contacts

5 contacts available for Dr. Liu Xiaoling: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/dr-liu-xiaoling?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Polaris Biology | Polaris Biology is a medical technology company specializing in the development and clinical application of cell-level precision diagnostic technology, is dedicated to exploring and studying individual and dynamic changes in tumors at the cellular level, and using this information to support clinical tumor diagnosis and treatment. | $8.3M | Series A | Jan 21, 2019 | http://www.polarisbiology.com |

1 of 1 investments shown.

## Co-investors
- [5Y Capital](https://shizune.co/investors/profile/morningsidevc) — VC Fund, 1 deal together
- [Volcanics Venture](https://shizune.co/investors/profile/volcanics-venture) — VC Fund, 1 deal together

## About Emerging Technology Partners

VC Fund · San Francisco, United States

Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.

1 contacts available at Emerging Technology Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Wei-Wu He | Founder & General Partner | https://shizune.co/investors/profile/wei-wu-he |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Dr. Liu Xiaoling invest in?

Dr. Liu Xiaoling invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Dr. Liu Xiaoling?

Public channels for Dr. Liu Xiaoling include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Dr. Liu Xiaoling last invest?

The most recent investment recorded for Dr. Liu Xiaoling closed in Jan 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co